The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.
The evolution of commercial drug delivery technologies
Abstract
Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. As therapeutic modalities expanded beyond small molecules to include nucleic acids, peptides, proteins and antibodies, drug delivery technologies were adapted to address the challenges that emerged. In this Review Article, we discuss seminal approaches that led to the development of successful therapeutic products involving small molecules and macromolecules, identify three drug delivery paradigms that form the basis of contemporary drug delivery and discuss how they have aided the initial clinical successes of each class of therapeutic. We also outline how the paradigms will contribute to the delivery of live-cell therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ultimate goal of the development of smart nanoparticles is that the payloads can better serve patients: enhance curative effect, reduce toxicity and prolong survival.276”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [276]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Research works printed but not linked: 2
- Dost, F. H. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, 1953).
- DeLoach, J. R. & Sprandel, U. (eds) in Bibliotheca Haematologica Vol. 51 (Karger, 1985).
Cited by
Sorted by citations
Items 801–900 of 1,000
Kesavan, A., Reddy, U. C., Kurian, J., & Muraleedharan, K. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103439 · Cited by 6
Setyawan, D., Amrillah, T., Abdullah, C. A. C., Ilhami, F. B., Dewi, D. M. M., Mumtazah, Z., Oktafiani, A., Adila, F. P., & Putra, M. F. H. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2175833 · Cited by 5
“[172], the analysis of the existing technology of next-generation biomedical suggests that there are at least three general challenges: (i) targeted delivery with single-cell or cell-compartment resolution, (ii) anticipating the biological barriers of the delivery of complex therapeutic molecules, and (iii) the develo…”
BackgroundClinical applications and future clinical trials of the drug delivery system
Çetin, K., Şarkaya, K., & Deni̇zli̇, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00020-1 · Cited by 5
Cao, Q., Yang, C., Yao Zong, Y. U. A. N., Li, B., Liu, J., Cao, Z., Liu, J., & Meng, X. (2023) · Materials Horizons · doi:10.1039/d3mh00077j · Cited by 5
Engineered Synthetic STxB for Enhanced Cytosolic Delivery
Hadjerci, J., Billet, A., Kessler, P., Mourier, G., Ghazarian, M., Gonzalez, A., Wunder, C., Mabrouk, N., Tartour, É., Servent, D., et al. (2023) · Cells · doi:10.3390/cells12091291 · Cited by 5
“Delivery approaches of pharmaceutical compounds have already contributed to the development and commercialization of therapeutic principles [1].”
BackgroundDrug delivery breakthrough technologies – A perspective on clinical and societal impact
Bittner, B., Sánchez-Félix, M., Lee, D., Koynov, A. A., Horvath, J. D., Schumacher, F. F., & Matoori, S. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.034 · Cited by 5
Mao, J., Jin, Z., Xue, R., Li, L., Hou, C., Leng, X., Bi, X., Chen, Z., Chen, Y., & Wang, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301099 · Cited by 5
Lee, J.-H., Yoo, E., & Choi, S. J. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.137613 · Cited by 5
Reddy, N. S., Choi, S., Park, S.-Y., Ha, C., Jung, Y., Chitumalla, R. K., Jang, J., Yoon, J.-Y., & Chung, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216470 · Cited by 5
“…delivery which is referred to as the release and absorption of active drug molecules or their subsequent transport through biological membranes to the site of action [16,21], often provides improved bioavailability of the drug moiety at the site of action with minimized systemic side effects [22].”
BackgroundSupramolecular Nano‐Grid Platform to Load and Deliver Liposomes and Exosomes
Li, J., Ma, W., Ren, X., Guo, T., Yang, B., Huang, C., Xiong, T., Guo, Y., Li, Z., Wang, S., et al. (2024) · Small Structures · doi:10.1002/sstr.202300487 · Cited by 5
On Interactions of Sulfamerazine with Cyclodextrins from Coupled Diffusometry and Toxicity Tests
Sofio, S. P. C., Caeiro, A., Ribeiro, A. C. F., Cabral, A. M. T. D. P. V., Valente, A. J. M., Canhoto, J., & Esteso, M. A. (2024) · Biomolecules · doi:10.3390/biom14040462 · Cited by 5
“The effective delivery of pharmaceutical compounds is a critical step in drug development technology [1].”
BackgroundAhmad, Z., Arshad, N., Alsaab, H. O., Selamoğlu, Z., & Shah, A. (2024) · Polymer Bulletin · doi:10.1007/s00289-024-05413-8 · Cited by 5
Material Trends and Clinical Costings in Systematically Identified CDER‐Approved Nanomedicines
Jarrett, T. R., Pregelj, L., Bell, C. A., Fletcher, N. L., & Thurecht, K. J. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400124 · Cited by 5
Mirtaleb, M. S., Khodabandeh, M., Deezagi, A., & Shafiee, D. (2025) · Scientific Reports · doi:10.1038/s41598-024-83731-7 · Cited by 5
Jiang, T., Guo, C., Zhang, Z., Li, C., Xiang, C., Xiang, J., Yang, X. W., Liu, Y., Cai, L., Gong, P., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02855d · Cited by 6
Pradhan, S. S., Upadhyay, A., Shrivastava, S., Singh, A., & Saha, S. (2025) · Polymer · doi:10.1016/j.polymer.2025.128222 · Cited by 5
Guo, R., Zhang, X., Fan, P., Song, B., Li, Z., Duan, Z., Qiao, Z., & Wang, H. (2021) · Angewandte Chemie · doi:10.1002/ange.202111839 · Cited by 5
Mahmoud, A., Nowell, C. J., Feeney, O. M., Hag, L. V. ‘., Davis, T. P., & Kempe, K. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00303 · Cited by 5
Kim, W. S., Jeong, S.-H., Shin, K., Lee, H. J., Park, J., Lee, I., Jeong, H. J., Ryu, Y. B., Kwon, H., & Lee, W. S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109635 · Cited by 5
“niques not only improve the solubility of drugs but also lower their instability against various in vivo risk factors (such as physiological temperature and pH changes) [15,16].”
Advantages of nanodrug targeting than conventional dosage system
Ulucan‐Karnak, F., & Kuru, C. İ. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00003-1 · Cited by 5
Sharaf, M., Mohammed, E. J., Farahat, E. M., Alrehaili, A. A., Alkhudhayri, A. A., Ali, A. M., Zahra, A. A., Zakai, S. A., Elkelish, A., Alharbi, M., et al. (2023) · Microbiology Research · doi:10.3390/microbiolres14040102 · Cited by 5
Exquisite Vesicular Nanomedicine by Paclitaxel Mediated Co‐assembly with Camptothecin Prodrug
Zhou, Z., Du, C., Zhang, Q., Yu, G., Zhang, F., & Chen, X. S. (2021) · Angewandte Chemie · doi:10.1002/ange.202108658 · Cited by 5
Secreted Particle Information Transfer (SPIT) – A Cellular Platform for In Vivo Genetic EngineeringPreprint
Charlesworth, C. T., Homma, S., Suchy, F. P., Wang, S., Bhadury, J., Amaya, A. K., Camarena, J., Zhang, J., Tan, T.-K., Igarashi, K. J., et al. (2024) · Research Square · doi:10.1101/2024.01.11.575257 · Cited by 6
Computational Approaches for Drug Delivery of Nanoparticles
Sharma, U., Khambete, H., Singh, N., Jain, S., Jain, N., & Dua, K. (2024) · doi:10.1002/9781394159338.ch9 · Cited by 5
Shinde, A. S., Patel, A. K., Mahapatra, N. R., Kar, S., & Santra, T. S. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c17618 · Cited by 4
Yan, X., Hua, L., Wan, H., Liu, Y., Jin, T., Ge, Y., Hamblin, M. R., Karimi, M., Zhao, X., Hu, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202507407 · Cited by 4
Zhou, Y., Zhang, H., Guo, W., Sun, C., & Duan, X. (2025) · Lab on a Chip · doi:10.1039/d5lc00640f · Cited by 4
3D-printed biopolymer-based microneedle for enhanced photodynamic therapy in melanoma treatment
Obalola, A. A., Abrahamse, H., & Kumar, S. S. D. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1642448 · Cited by 6
“…innovations that have the potential to control how pharmacologically active substances are released and transported into tissues, cells, and organs such that these active substances can have the greatest possible effects are collectively referred to as drug delivery systems (DDS) (65, 66).”
Shirazi, M. M. A., Haghighat, S., Nikbakht, Z., Salimkia, E., & Kiumarsy, A. (2025) · Virus Research · doi:10.1016/j.virusres.2025.199642 · Cited by 5
“This “ bench-to-bedside ” pipeline highlights the interdisciplinary integration of computational biology, nanomedicine, and clinical sciences in AVP development (Agarwal and Gabrani, 2021; Vargason et al., 2021).”
Zhao, W., Sun, K., Wang, W., Sun, Y. Y., & Wei, D. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169540 · Cited by 4
Axioti, E., Mehner, F., Reynolds‐Green, M., Bukane, A. R., Cavanagh, R. J., Michel, S., Auernhammer, G. K., Taresco, V., & Gaitzsch, J. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500432 · Cited by 4
Chrono-Colonic Delivery in Engineering Time-Responsive Systems for Site-Specific Therapy
Sarkar, R., Biswas, P., Mukherjee, D. R., Tanbir, S., Biswas, B., Rahaman, M. M., & Santra, S. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i10.7398 · Cited by 4
“They are also widely used for colon-targeted drug delivery where high localized concentrations or protection from enzymatic degradation in the upper gastrointestinal tract is required 44 .”
β-Glucans in Food Systems: Balancing Health, Safety, and Diabetes Prevention
Liu, X., Feng, Y., Song, Y., Wang, J., Duan, Y., & Liu, G. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c12704 · Cited by 4
Liu, J., Zhang, Y., Zhang, B., Jiao, R., Fan, Q., Liu, Q., Chen, M., Hong, G., Liao, W., Zhao, Z., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c13606 · Cited by 4
Delivery science: Its increasing importance for the next generation of medicines
Ashford, M. B., & Bak, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114663 · Cited by 5
Murcko, M. A. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03222 · Cited by 7
Tazehabadi, M. J. M., & Ansari, M. (2026) · Annals of Biomedical Engineering · doi:10.1007/s10439-026-04017-9 · Cited by 4
“Therefore, the recent improvements in the biomedical engineering field have resulted in therapeutic efficiency, and using suitable delivery systems has contributed to the improvement of medical field [14–16].”
Enhanced Transcytosis and Retention (ETR) of Drug Delivery Nanocarrier in Solid Tumors
Qin, M., Zhang, Z., Zhao, Y., & Meng, H. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00062 · Cited by 4
Seshire, A., Duan, Y., & Lang, K. (2024) · Handbook of experimental pharmacology · doi:10.1007/164_2024_723 · Cited by 4
AI and machine learning in pharmaceutical formulation and manufacturing of personalized medicines
Gupta, A., Vaidya, K., & Boehnke, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91819-0.00006-3 · Cited by 6
CRISPR/Cas9 gene editing: A new hope for Alzheimer's disease
Shareena, G., Viswalingam, V., Rajput, M. S., & Kumar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00014-5 · Cited by 4
Investigating Non-Covalent Interactions of Human Serum Albumin with Doxorubicin and Folic Acid
Bauer, I., & Dmitrienko, E. V. (2024) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750823600413 · Cited by 5
“The other is in the design of delivery systems: nanoparticles, liposomes, and hydrogels [11].”
Anti-hepatoma effect of homologous delivery of doxorubicin by HepG2 cells
Sun, L., Ma, B., Yang, F., Zou, H., Guo, Y., Wang, X., & Han, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125113 · Cited by 5
Multivalent ionizable lipid-polypeptides for tumor-confined mRNA transfection
Zhao, X., Zhang, Y., Wang, X., Fu, Z.-M., Zhong, Z., & Deng, C. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.12.032 · Cited by 5
Surface chemistry tailorable quantum dots mediated direct cytosolic delivery of proteins
Son, H., Lee, S., Lee, J., Kim, S., Kang, M., & Park, J. (2025) · Surfaces and Interfaces · doi:10.1016/j.surfin.2025.106096 · Cited by 4
Yücel, Y., Şeker, F. S., Erden, B. A., Özdemir, M., Tekin, Ç. S., Çalışkan, E., Tekin, S., Koran, K., & Biryan, F. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70233 · Cited by 4
Rolling circle replication based nucleic acid nanostructures for programmable drug delivery
Yang, K., Nam, K., Park, K. H., Shin, H. K., Kim, Y., & Roh, Y. H. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00293a · Cited by 4
Electrochemical Single‐Cell Protein Therapeutics Using a Double‐Barrel Nanopipette
Shi, X., Xu, Y., Zhou, B., Wang, B., Yu, S., Zhao, W., Jiang, D., Chen, H., & Xu, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202215801 · Cited by 4
Wu, C., Sun, Q., Liu, X., Sun, X. S., Chen, Z., & Han, S. (2023) · Micromachines · doi:10.3390/mi15010090 · Cited by 4
“The development of efficient drug delivery systems is crucial for enhancing the therapeutic efficacy of anticancer agents while minimizing their adverse effects on healthy tissues [1–4].”
BackgroundFreezing-mediated formation of supraproteins using depletion forces
Song, J., Tas, R. P., Martens, C. M., Ritten, M. V. M., Wu, H., Jones, E. R., Lebouille, J. G. J. L., Vis, M., Voets, I. K., & Tuinier, R. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.03.088 · Cited by 4
Ahmed, A., Ahmad, R., Jangir, S., & Sharma, D. (2024) · The Natural Products Journal · doi:10.2174/0122103155281428240320091344 · Cited by 4
Lu, Y., & Hu, G. (2024) · Applied Physics Letters · doi:10.1063/5.0209853 · Cited by 4
Photodynamic therapy using polymeric micelles containing photosensitizers
Uruma, Y., Yao, H., Altannavch, B., Hara, N., Lü, Q., & Lai, P. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101499 · Cited by 4
Jin, X., Heidari, G., Nezhad, S. M., Shao, M., Hua, Z., Lei, Y., Zare, E. N., Paiva‐Santos, A. C., Sillanpää, M. E. T., Prakash, C., et al. (2024) · Alexandria Engineering Journal · doi:10.1016/j.aej.2024.04.074 · Cited by 4
Crystallization inhibition and enhanced release of nobiletin in supramolecular peptide assemblies
Zhu, X., Yuan, J., Chang, R., Fan, W., Wang, Y., Li, H., Zhang, Y., Zhou, P., & Yan, X. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.134331 · Cited by 4
Pecorini, G., Votta, A., Tiralongo, G., Volpi, D., Ferraro, E., & Puppi, D. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105895 · Cited by 4
Smidt, J. M., Märcher, A., Skaanning, M. K., El‐Chami, K., Teodori, L., Omer, M., Kjems, J., & Gothelf, K. V. (2024) · ChemBioChem · doi:10.1002/cbic.202400437 · Cited by 4
PEPTIDE DELIVERY VIA NASAL ROUTE: EXPLORING RECENT DEVELOPMENTS AND APPROACHES
PALDE, C., Barot, T., Chakraborthy, G. S., & PATEL, L. D. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i4.50626 · Cited by 4
“Another noteworthy example is Afrezza, [45], which utilizes microparticles formulated with fumaryl diketopiperazine to deliver insulin via inhalation.”
BackgroundInfluentialKamaraj, C., Naveenkumar, S., Prem, P., Al‐Ghanim, K. A., Vimal, S., Jayaseelan, C., Balashanmugam, P., & Priyadharsan, A. (2024) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2024.07.039 · Cited by 4
Kinoshita, T., Sakamaki, D., & Fukuhara, G. (2024) · ACS Omega · doi:10.1021/acsomega.4c03584 · Cited by 4
Review of commercially available nano-drugs and nano-delivery systems: challenges and perspectives
Boudovitch, D., Sakaya, A., Uzundurukan, A., Leroux, J.-Y., & Fuoco, D. (2023) · 4open · doi:10.1051/fopen/2024002 · Cited by 4
Casanova, M., Vanelle, P., Azas, N., & Broggi, J. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100394 · Cited by 5
Species Selection for Pharmaceutical Toxicity Studies
Harvey, W. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_133 · Cited by 4
A single molecule carrier for ocular posterior segment diseases
Zhang, X., Yue, Y., Yang, Y., Ying, A., Ma, R., Chen, J., Chen, F., Hou, X.-Y., Pan, Y., Ren, D.-Z., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.052 · Cited by 4
Kaur, H., & Kishore, N. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.135691 · Cited by 4
Álvarez-Martínez, J. U., Medina, O. M., González-Vega, A., Segura-Gómez, G., Gutiérrez-Juárez, G., & Castro‐Beltrán, R. (2024) · Journal of Micromechanics and Microengineering · doi:10.1088/1361-6439/ad983c · Cited by 4
“…to whom any correspondence should be addressed. is particularly critical in applications such as drug delivery systems for therapeutic purposes [4], microdosing liposome compositions in drug delivery [5], high-throughput detection and screening of disease biomarkers [6], and laser-based…”
Nanobots: The future of drug delivery
Rao, T. R., & Aditya, A. (2024) · Ars Pharmaceutica (Internet) · doi:10.30827/ars.v65i4.31068 · Cited by 4
da Costa, A. L. P., Oliveira, G. S., Silva, A. C. D. J., Andrade, A. C. F., Ramos, J. S., Souza, K. R. C. D., Sousa, R. D. O., Ramos, A. S., & Hage-Melim, L. I. D. S. (2024) · Engineering materials · doi:10.1007/978-3-031-75984-0_20 · Cited by 4
Seong, J., Kim, M., Yoo, J., Mack, D. L., Lee, J. H., & Joo, J. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c19961 · Cited by 4
Innovations in Healthcare: Carbon nanoarchitectonics for multifunctional therapies
Dan, M., Singh, P., Mathew, R., Agrawal, M., & Singh, S. (2025) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2025.01.057 · Cited by 4
Kuno, S., Pakpian, N., & Muanprasat, C. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177351 · Cited by 4
Helical Polymers as Drug Delivery Carriers
Li, T., Zong, Y., Chen, Z., Luo, J., Na, L., & Wu, Z. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.202401635 · Cited by 6
Sharma, R., Kumar, S., Komal, K., Ghosh, R., Thakur, S., Pal, R. R., & Kumar, M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04094-y · Cited by 4
“Polymeric nanoparticles represent three main advantages in drug administration namely the size, shape, and surface charge which are modifiable and controllable (Vargason et al. 2021).”
Characterization of Azido-Incorporated Bombyx mori Silk Fibroin as a Drug Carrier Material
Tian, Y., & Teramoto, H. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00232 · Cited by 4
Amyloid-liposome composites as hybrid platforms for doxorubicin delivery
Trusova, V. M., Malovytsia, U., Vus, K. O., Zhytniakivska, O. A., & Gorbenko, G. P. (2025) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2025.184426 · Cited by 4
Emergency delivery of particulate drugs by active ejection using in vivo wireless devices
Krishnan, S. R., O’Keeffe, L., Rudra, A., Gumustop, D. R., Khatib, N., Liu, C., Yang, J., Wang, A., Bochenek, M. A., Lu, Y., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01436-2 · Cited by 5
“Many soluble drugs, ranging from proteins and peptides to antibodies and nucleic acids, suffer from low stability and short half-lives in the presence of water at physiological temperature 1 .”
Stability Testing of Amoxicillin Nano-suspension as Promising Tool for Drug Delivery System
Eltaib, L., & Mujtaba, M. A. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i60b34903 · Cited by 4
Balaji, S., Karthikeyan, R., Kiran, V., Yuvaraj, B. Y., Nagaraj, S., Manivannan, S., & Narayan, S. (2022) · Current Ophthalmology Reports · doi:10.1007/s40135-022-00285-5 · Cited by 4
Macromolecular Effects in Medicinal Chemistry※
Zhao, J., Song, W., Tang, Z., & Chen, X. (2022) · 化学学报 · doi:10.6023/a21120602 · Cited by 4
Cheng, L., Lu, L., Chen, Z., Ma, D., & Xi, Z. (2022) · Molecules · doi:10.3390/molecules27206943 · Cited by 4
“For this kind of vector, the balance of gene-loading capacity and nanoparticle size is critical to ensure the high performance of the combination strategy [14,15].”
BackgroundDirect cardiac reprogramming: basics and future challenges
Andrianto, A., Mulia, E. P. B., & Luke, K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07913-0 · Cited by 4
Microsponges: An Emerging Formulation Tool for Topical Drug Delivery
Wani, S. P., Shinkar, D. M., Pingale, P. L., Boraste, S. S., & Amrutkar, S. V. (2022) · Pharmacophore · doi:10.51847/evxrf0bgo6 · Cited by 4
Weidner, E., Bartczak, P., Gościańska, J., Jesionowski, T., Jaroniec, M., & Ciesielczyk, F. (2023) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2023.112487 · Cited by 4
Drug Absorption via the Nasal Route: Opportunities and Challenges
Amponsah, S. K., & Adams, I. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_3 · Cited by 4
Engineering of Therapeutic and Detoxifying Enzymes
Michailidou, F. (2023) · Angewandte Chemie · doi:10.1002/ange.202308814 · Cited by 4
Electronic drug delivery systems
Sahini, M. G., & Banyikwa, A. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91668-4.00024-1 · Cited by 4
Rajendran, R., Arunachalam, J. P., Chidambaram, S., Srikanth, K., Krishnamurthy, B., Vinayagam, S., Veeravarmal, V., Prasad, H., Verma, K., & Anoop, U. R. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00184 · Cited by 4
Yılmaz, K., Gübbük, İ. H., & Maltaş, E. (2023) · Macromolecular Research · doi:10.1007/s13233-023-00202-0 · Cited by 4
“Drug systems such as tablets, capsules, syrups, and ointments are not suitable to achieve sustained release [1–5].”
Chen, X., Hsu, F.-C., Huang, K.-Y., Hsieh, T.-S., Farn, S., Sheu, R.-J., & Yu, C. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129744 · Cited by 4
Cell-Penetrating Drug Carrier by Molecular Recognition of Sphingomyelin on Plasma Membranes
Cheng, X., Miao, Y., Zhou, J., Lu, F., Jin, J., & Hu, L. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c00101 · Cited by 4
New cellular models to support preclinical studies on ICAM-1-targeted drug delivery
Vigo, M., Haro-Martínez, E., Ruiz, E. F., Navarro, J. F., Placci, M., & Muro, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106170 · Cited by 4
Ultrasound-dependent RNAi using TatU1A-rose bengal conjugate
Sumi, N., Nagahiro, S., Nakata, E., Watanabe, K., & Ohtsuki, T. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128767 · Cited by 4
Functionalization of Luminescent Lanthanide Complexes for Biomedical ApplicationsPreprint
Xian, T., Meng, Q., Gao, F., Hu, M., & Wang, X. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4088391 · Cited by 4
Eskandari, A., Wang, Y., & Forgan, R. S. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-mhb04 · Cited by 4
Integration of a fully automated flow cytometry system with high robustness into a Screening Station
Fujiyama, S., Asano, H., & Namatame, I. (2024) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2024.100215 · Cited by 3
Dai, Q., Wang, J., Lin, Z., Yu, D., Yang, H., Zhang, J., Li, X., Zeng, J., Hu, H., Ni, C., et al. (2025) · Small Methods · doi:10.1002/smtd.202500425 · Cited by 3
Wu, Y., Kawamoto, Y., Sun, J., Takahashi, Y., Higuchi, Y., & Takakura, Y. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01070-5 · Cited by 3
Recent Advancement in Drug Delivery Systems for the Treatment of Rheumatoid Arthritis
Singh, N., & Choudhary, R. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638376838250701221200 · Cited by 3
Xu, Y., Ye, L., Li, Z., Zhang, Y., Hua, N., Wang, X., Lu, W., Xi, J., Chen, L., Xu, C., et al. (2025) · MedComm · doi:10.1002/mco2.70271 · Cited by 3
“…on intracranial drug delivery has been increasing, Gao, Tylawsky, and others have found that utilizing nanoparticle delivery systems and the phagocytic clearance ability of microglia enables targeted drug delivery to specific microenvironments in the brain, thereby reducing drug toxicity [55–57].”
Umekar, M. J., Raut, N., Mahore, J., Malode, D., Koche, S., Manghani, M., & Trivedi, R. (2025) · Polymer-Plastics Technology and Materials · doi:10.1080/25740881.2025.2546457 · Cited by 3
“[33]”
Metadata
- Authors
- Vargason, A. M., Anselmo, A. C., & Mitragotri, S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Corresponding author
- Mitragotri, Samir
- Venue
- Nature Biomedical Engineering
- Published
- 2021-04-01
- Volume
- 5
- Issue
- 9
- Pages
- 951-967
- ISSN
- 2157-846X (ISSN-L)
- OpenAlex
- W3143156272
- Cited by
- 1,361
- References
- 275
- Citations by year
- 2026: 170 · 2025: 314 · 2024: 366 · 2023: 293 · 2022: 170 · 2021: 48
- FWCI
- 19.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (DGE-1650116)
- U.S. Department of Health & Human Services | National Institutes of Health (R35GM137898, 1R01HL143806-01)
- United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-1-0045)
- U.S. Department of Defense (W81XWH-19-2-0011)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug delivery technology, small molecules, macromolecules, nucleic acids, proteins, immunoglobulins, medication adherence
- MeSH terms
- Pharmaceutical Preparations, Humans, Nucleic Acids, Peptides, Proteins, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review